cerebrospinal fluid of patients with relapsing–remitting multiple sclerosis (RRMS). The
current study aimed at assessing possible changes in the serum Klotho concentration of MS
patients. Participants involved 15 new cases of RRMS patients in the relapse phase, 15
RRMS patients who had been suffering from the disease for more than three years and were
under regular treatments (interferon beta-1a) and, finally, 15 non-MS patients who …